Genome&Company

314130 KRX Pharmaceuticals Pharmaceuticals

KOSDAQ

₩3,250.00

-1.52%

Delayed · cached 15 min

Frequently asked questions

What sector does Genome&Company belong to?

Genome&Company operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.

What is the current share price of 314130?

As of the latest available quote, 314130 traded at ₩3,250.00. This price is delayed and cached for about 15 minutes.

What is the market capitalisation of 314130?

The market capitalisation of Genome&Company is approximately ₩121.86B.

Is Genome&Company profitable?

For its latest reported financial year, Genome&Company recorded a negative net profit margin of about -31.26% (a net loss for the latest period).

What is the return on equity (ROE) of 314130?

Genome&Company has a return on equity (ROE) of about -6.08%. ROE measures how much profit a company generates relative to shareholders' equity.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.